Demographic and clinical characteristics of Guillain-Barré syndrome at Kenyatta National Hospital, Kenya.

IF 2.4 Q3 CLINICAL NEUROLOGY
BMJ Neurology Open Pub Date : 2025-06-08 eCollection Date: 2025-01-01 DOI:10.1136/bmjno-2025-001074
Stephen Kivuva Muindi, Mohamed Onyango, Moses Muia Masika
{"title":"Demographic and clinical characteristics of Guillain-Barré syndrome at Kenyatta National Hospital, Kenya.","authors":"Stephen Kivuva Muindi, Mohamed Onyango, Moses Muia Masika","doi":"10.1136/bmjno-2025-001074","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Guillain-Barré Syndrome (GBS) is a life-threatening neurological disorder with limited data from sub-Saharan Africa. This study describes the clinical features, outcomes and predictors of mortality among GBS patients at Kenyatta National Hospital in Nairobi, Kenya.</p><p><strong>Methods: </strong>This cross-sectional study used retrospective data from patient files obtained from the Health Information Department from 2014 to 2023 on 207 GBS patients. A census of all available patient files meeting inclusion criteria was done. Demographic and clinical data were collected; descriptive and correlation analyses were performed using IBM SPSS Statistics V.25.0.</p><p><strong>Results: </strong>The male to female ratio was 1.01:1. The median age was 21 years. A quarter of cases were in the 0-5 years age group. HIV and hypertension were the most common comorbidities, particularly in females. Clinical manifestations included hyporeflexia, hypotonia and sensory loss. Significant morbidity was observed, with 25.7% experiencing respiratory complications and 35.4% requiring intensive care. Female patients had increased mortality risk (adjusted OR (aOR)=4.03, 95% CI: 1.15 to 14.11, p=0.029). HIV-positive females had over sevenfold higher odds of death (aOR 7.21, 95% CI: 1.56 to 33.36, p=0.011), while intravenous immunoglobulin (IVIg) use reduced mortality by 75% (aOR 0.25, 95% CI: 0.08 to 0.85, p=0.026).</p><p><strong>Conclusion: </strong>This study highlights GBS's demographic, clinical and outcome aspects in Kenya. GBS predominates in young individuals. Females experience higher comorbidity and mortality rates. Improving access to IVIg, intensive care unit and early supportive management is essential. Further research is needed to explore gender-based mortality differences and age-related morbidity variations.</p>","PeriodicalId":52754,"journal":{"name":"BMJ Neurology Open","volume":"7 1","pages":"e001074"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12161362/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Neurology Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmjno-2025-001074","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Guillain-Barré Syndrome (GBS) is a life-threatening neurological disorder with limited data from sub-Saharan Africa. This study describes the clinical features, outcomes and predictors of mortality among GBS patients at Kenyatta National Hospital in Nairobi, Kenya.

Methods: This cross-sectional study used retrospective data from patient files obtained from the Health Information Department from 2014 to 2023 on 207 GBS patients. A census of all available patient files meeting inclusion criteria was done. Demographic and clinical data were collected; descriptive and correlation analyses were performed using IBM SPSS Statistics V.25.0.

Results: The male to female ratio was 1.01:1. The median age was 21 years. A quarter of cases were in the 0-5 years age group. HIV and hypertension were the most common comorbidities, particularly in females. Clinical manifestations included hyporeflexia, hypotonia and sensory loss. Significant morbidity was observed, with 25.7% experiencing respiratory complications and 35.4% requiring intensive care. Female patients had increased mortality risk (adjusted OR (aOR)=4.03, 95% CI: 1.15 to 14.11, p=0.029). HIV-positive females had over sevenfold higher odds of death (aOR 7.21, 95% CI: 1.56 to 33.36, p=0.011), while intravenous immunoglobulin (IVIg) use reduced mortality by 75% (aOR 0.25, 95% CI: 0.08 to 0.85, p=0.026).

Conclusion: This study highlights GBS's demographic, clinical and outcome aspects in Kenya. GBS predominates in young individuals. Females experience higher comorbidity and mortality rates. Improving access to IVIg, intensive care unit and early supportive management is essential. Further research is needed to explore gender-based mortality differences and age-related morbidity variations.

肯尼亚肯雅塔国家医院格林-巴罗恩综合征的人口学和临床特征。
背景:吉兰-巴罗综合征(GBS)是一种危及生命的神经系统疾病,来自撒哈拉以南非洲的数据有限。本研究描述了肯尼亚内罗毕肯雅塔国家医院GBS患者的临床特征、结局和死亡率预测因素。方法:本横断面研究采用2014年至2023年卫生信息部门获得的207例GBS患者档案的回顾性数据。对所有符合纳入标准的患者档案进行普查。收集人口统计学和临床数据;使用IBM SPSS Statistics V.25.0进行描述性和相关性分析。结果:男女比例为1.01:1。中位年龄为21岁。四分之一的病例发生在0-5岁年龄组。HIV和高血压是最常见的合并症,尤其是在女性中。临床表现为反射减退、张力减退和感觉丧失。发病率显著,25.7%出现呼吸系统并发症,35.4%需要重症监护。女性患者死亡风险增加(调整后OR =4.03, 95% CI: 1.15 ~ 14.11, p=0.029)。艾滋病毒阳性女性的死亡率高出7倍以上(aOR 7.21, 95% CI: 1.56至33.36,p=0.011),而静脉注射免疫球蛋白(IVIg)可使死亡率降低75% (aOR 0.25, 95% CI: 0.08至0.85,p=0.026)。结论:本研究突出了肯尼亚GBS的人口学、临床和结局方面。GBS主要发生在年轻人身上。女性的合并症和死亡率更高。改善获得IVIg、重症监护病房和早期支持性管理的机会至关重要。需要进一步的研究来探索基于性别的死亡率差异和与年龄相关的发病率变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMJ Neurology Open
BMJ Neurology Open Medicine-Neurology (clinical)
CiteScore
3.20
自引率
3.70%
发文量
46
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信